Hospital News and Research

RSS

Amakem receives €18m in Series A round of funding

Amakem NV today announced it has raised €18m with a syndicate of leading life sciences investors to advance its ophthalmology drug development portfolio and progress its lead candidate, AMA0076 for glaucoma, to clinical proof of concept.

6 Sep 2011

Major difference in twin birth weights linked to increased risk of health complications

The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.

6 Sep 2011

Moderate to severe cognitive impairment has impact on life expectancy

Cognitive impairment, even when detected at an early, mild stage, is a significant predictor of decreased life expectancy.

6 Sep 2011

Researchers discover how yeast cells identify, attach to human tissue and cause infection

Researchers are a step closer towards creating a new class of medicines and vaccines to combat drug-resistant and deadly strains of fungal infections, following a new study published today in Proceedings of the National Academy of Sciences.

6 Sep 2011

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces oral communication of the Phase II clinical trial results of its orphan product Livatag at the annual congress of ILCA, the only international organization devoted exclusively to liver cancer research with participation of worldwide best specialists.

6 Sep 2011

Mesoblast receives EMA clearance to initiate Revascor Phase 2 trial for heart attacks

Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.

5 Sep 2011

Australia’s Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or “off-the-shelf”, adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

5 Sep 2011

Alcohol related teen hospitalizations higher in areas with more off-licenses: Study

New research shows that the more off-license stores a town boasts of, the greater the number of under-age drinkers who are likely to end up in hospital as a result of harmful drinking.

5 Sep 2011

Circumcision rates decline in the US: Study

A new study has shown that circumcision rates among US baby boys have fallen. According to the Centers for Disease Control and Prevention (CDC), which published the study in the Morbidity and Mortality Weekly Report, circumcision rates dropped from around 62 percent in 1999 to 57 percent in 2008.

5 Sep 2011

Stroke in the young on the rise: Study

A new study has revealed that more children and young adults in the U.S. are having strokes. Researchers speculate that unhealthy lifestyles could be a likely contributor.

5 Sep 2011

Researchers discover gene mutation linked with lymphoedema, leukaemia

Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia.

5 Sep 2011

Inflammation boosts activity of two proteins that can normalize blood sugar in diabetics

Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice.

5 Sep 2011

Exposure to household smoke increases school absenteeism among children

Children who live in households where they are exposed to tobacco smoke miss more days of school than do children living in smoke-free homes, a new nationwide study confirms.

5 Sep 2011

Radiologists should become knowledgeable with regard to meaningful use

Authors of a study in the September issue of the Journal of the American College of Radiology say, with an estimated $1.5 billion in potential bonus payments for radiology professionals at stake, radiologists should study and respond to recent federal regulations related to meaningful use of complete certified ambulatory electronic health records and their equivalents.

3 Sep 2011

Immigrant dialysis patients in Atlanta again face treatment crisis

After the collapse of negotiations between Atlanta's public hospital and the world's largest dialysis provider, a dozen immigrants suffering from renal failure were refused treatment at an Atlanta clinic on Thursday and advised to wait until their conditions deteriorated enough to justify life-saving care in an emergency room. Unless the deadlock is broken, 22 patients, most of them illegal immigrants, face a debilitating cycle.

3 Sep 2011

Feds hold off on decision about yanking Medicare funding to Parkland

The CMS has extended the possible date of Parkland Health and Hospital System's termination from the Medicare program to Sept. 30 from Sept. 2 in order to give state surveyors more time to complete their reports. The 672-bed Parkland received word Aug. 9 that it was under threat of losing its status as a Medicare provider, and after submitting its plan of action (PDF) on how it would correct the problems by an Aug. 20 deadline.

3 Sep 2011

Hospital executives should consider value-added services of radiology groups

Hospital executives should consider the value-added services of hospital-based radiology groups before allowing radiology departments to be taken over by teleradiologists or other specialists, according to an article in the September 2011 issue of the Journal of the American College of Radiology.

3 Sep 2011

UCF, UF receive $5.5 million NIH grant for hemophilia research

At a time when research funding is hard to come by, a University of Central Florida and University of Florida partnership has landed almost $5.5 million in National Institutes of Health highly competitive grants for hemophilia research.

3 Sep 2011

Novel analysis of MRI scans reveals distinct features of autistic brain

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have used a novel method for analyzing brain-scan data to distinguish children with autism from typically developing children.

3 Sep 2011

Study finds link between long-term dietary patterns and human gut bacteria

"You are what you eat" is familiar enough, but how deep do the implications go? An interdisciplinary group of investigators from the Perelman School of Medicine at the University of Pennsylvania have found an association between long-term dietary patterns and the bacteria of the human gut.

3 Sep 2011